Bixiye
QP82-18 Pharmacy Benefit Exclusion for Azedra (iobenguane I 131) Intravenous Injection
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 28, 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2781 - 2790 ee natiijooyinka 3167
Bixiye
QP81-18 Changes to Cotiviti Mailroom Operations Center Location
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 25, 2018
Bixiye
QP80-18 Universal Pharmacy Policy for MHCP Subscribers - Immediate Release and Extended Release Opioids Initial Fill Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 24, 2018
Bixiye
QP79-18 Addition of Drug to the Hereditary Angioedema Prior Authorization with Quantity Limit Program
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 21, 2018
Bixiye
QP60R1-18 Update: Change to Call Center for Transportation for MHCP Members
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 14, 2018
Bixiye
QP78-18 Pharmacy Update - Change in Coverage for Brand Serevent Diskus 50 mcg/dose
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 11, 2018
Bixiye
QP77-18 Pharmacy Benefit Exclusion for Onpattro (patisiran) Lipid Complex Intravenous (IV) Injection
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 11, 2018
Bixiye
QP75-18 2018 Blue Cross Blue Shield MHCP Migration and New Initiatives Training
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 07, 2018
Bixiye
QP76-18 Migration of Minnesota Health Care Programs Subscribers to Amerigroup
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 06, 2018
Bixiye
P40-18 Blue Cross to Post Provider Quick Points Twice per Month on Standard Schedule
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 04, 2018